Table 5.
Variables | Crude estimates | Adjusted estimates | ||
---|---|---|---|---|
OR (95% CI) | p values | AOR (95% CI) | p values | |
Sex | ||||
Male | Ref | Ref | ||
Female | 0.85 (0.44, 1.66) | 0.638 | 1.07 (0.5, 2.33) | 0.858 |
Age | ||||
<50 | Ref | Ref | ||
50-75 | 1.3 (0.4, 4.24) | 0.668 | 1.5 (0.36, 6.04) | 0.588 |
75+ | 2.1 (0.52, 8.7) | 0.295 | 2.53 (0.46, 13.94) | 0.286 |
Level of education | ||||
None | Ref | Ref | ||
Primary | 0.8 (0.07, 9.1) | 0.855 | ||
Secondary+ | 0.53 (.05, 6.19) | 0.615 | 0.450 | |
Salt reduction in food | ||||
No | Ref | Ref | ||
Yes | 0.55 (0.28, 1.1) | 0.092 | 0.55 (0.24, 1.22) | 0.142 |
Antihypertensive | ||||
ACE inhibitors | Ref | Ref | ||
ARB | 2.63 (1.13, 6.11) | 0.025 | 2.27 (0.94, 5.46) | 0.068 |
CCB | 12.86 (3.98, 41.59) | <0.001 | 10.9 (3.29, 36.09) | <0.001 |
Combination therapy | 2.79 (0.99, 7.82) | 0.052 | 2.27 (0.77, 6.72) | 0.139 |
Other medications | 2.1 (0.56, 7.57) | 0.278 | 1.64 (0.42, 6.38) | 0.475 |
Family history of HTN | ||||
No | Ref | Ref | ||
Yes | 2.33 (1.13, 4.79) | 0.022 | 1.83 (0.82, 4.1) | 0.142 |